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Abstract 
Background: Abdominal visceral obesity has been reported to be associated with cardiovascular risks than body 
mass index, waist circumference, and abdominal subcutaneous fat. On the other hand, there is evidence that sub-
cutaneous fat has a beneficial role against cardio-metabolic risks such as diabetes or dyslipidemia. However, little is 
known regarding the association between high visceral fat with low subcutaneous fat accumulation and the risk for 
atherosclerosis.
Methods: This study was designed to elucidate whether high visceral fat with low subcutaneous fat accumulation 
enhances the risk for atherosclerosis in patients with type 2 diabetes. This is a cross-sectional study of 148 patients 
with type 2 diabetes (mean age 65 ± 12 years; 44.5 % female). Visceral fat area (VFA, cm2) and subcutaneous fat area 
(SFA, cm2) were assessed by abdominal computed tomography. Carotid intima media thickness (CIMT, mm) meas-
ured by ultrasonography was used for the assessment of atherosclerosis. Patients were divided into four groups: 
SFA < 100 cm2 and VFA < 100 cm2 [S(−)V(−)], SFA ≥ 100 cm2 and VFA < 100 cm2 [S(+)V(−)], SFA < 100 cm2 and 
VFA ≥ 100 cm2 [S(−)V(+)], and SFA ≥ 100 cm2 and VFA ≥ 100 cm2 [S(+)V(+)]. Linear regression analysis with a step-
wise procedure was used for the statistical analyses.
Results: Among the patients examined, 16.3 % were S(−)V(+). Mean (95 % confidence interval) of CIMT adjusting 
for age and gender were 0.80 (0.69–0.91), 0.86 (0.72–1.01), 1.28 (1.11–1.44) and 0.83 (0.77–0.88) in patients with S(−)
V(−), S(+)V(−), S(−)V(+) and S(+)V(+), respectively (p < 0.001). The S(−)V(+) patients exhibited significantly older 
than S(−)V(−) patients and those with S(+)V(+) and had a highest VFA-SFA ratio (V/S ratio) among the four groups. 
S(−)V(+) patients were male predominant (100 % male), and S(+)V(−) patients showed female predominance (82 % 
female). In multivariate linear regression analysis (Adjusted R2 = 0.549), S(−)V(+) was significantly associated with 
CIMT (Standardized β 0.423, p < 0.001). Notably, S(+)V(+) was inversely associated with CIMT in the multivariate 
model.
Conclusions: This study provides evidence that high visceral fat with low subcutaneous fat accumulation is an 
important determinant of carotid atherosclerosis and high subcutaneous fat could be protective against atherosclero-
sis in patients with type 2 diabetes.
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carotid intima media thickness (CIMT) using an echoto-
mographic system (Aplio XG SSA790A, Toshiba Medical 
Systems, Tochigi, Japan) with a 7.5-MHz linear trans-
ducer, as reported previously [11]. Following the criteria 
of visceral fat obesity as recommended by the Japan Soci-
ety for the Study of Obesity [12], we defined visceral and 
subcutaneous fat accumulation; they were classified into 
four groups as follows: SFA < 100 cm2 and VFA < 100 cm2 
[S(−)V(−)], SFA  ≥  100  cm2 and VFA  <  100  cm2 [S(+)
V(−)], SFA  <  100  cm2 and VFA ≥  100  cm2 [S(−)V(+)] 
and SFA ≥ 100 cm2 and VFA ≥ 100 cm2 [S(+)V(+)].
Statistical analysis
Statistical analysis was performed using programs availa-
ble in the SPSS version 21.0 statistical package (SPSS Inc., 
Chicago, IL, USA). Data are presented as mean  ±  SD 
or geometric mean with 95  % confidence interval (CI) 
as appropriate according to data distribution. Differ-
ences among the four groups were tested with a one-way 
ANOVA (continuous variables) or Chi square test (cate-
gorical variables) followed by Tukey–Kramer methods for 
the post hoc analyses. Linear regression analysis with a 
stepwise procedure was used to assess the cross-sectional 
association of each manifestation of abdominal (VFA) 
and subcutaneous (SFA) fat accumulation with carotid 
atherosclerosis. The following covariates were incorpo-
rated into the analysis; age, gender, duration of diabetes, 
smoking status, systolic blood pressure, triglycerides, 
high-density lipoprotein (HDL) cholesterol, low-density 
lipoprotein (LDL) cholesterol, HbA1c, urinary albumin-
to-creatinine ratio (ACR), eGFR, and the use of insulin, 
the use of calcium channel blockers (CCBs), angioten-
sin-converting enzyme inhibitors, angiotensin receptor 
blockers (ARBs), statins, and anti-platelet agents. We also 
underwent a sensitivity analysis to examine the associa-
tion of VFA and SFA with CIMT, using the cutoff of 100 
and 150  cm2 in VFA and SFA, respectively, because the 
average of SFA in this study was approximately 150 cm2. 
Differences were considered to be statistically significant 
at p value less than 0.05.
Results
A total of 148 Japanese patients with type 2 diabetes 
(mean age 65 ±  12  years; 44.5  % female) were enrolled 
in this study. Among the participants, 16.3  % (N =  11) 
were classified as S(−)V(+), and 23.0 % (N = 34), 26.4 % 
(N  =  39) and 43.2  % (N  =  64) were classified as S(−)
V(−), S(+)V(−), and S(+)V(+), respectively (Fig. 1). As 
shown in Table  1, S(−)V(+) patients were older than 
Background
Obesity has been reported to be associated with insulin 
resistance, dyslipidemia, and hypertension, thus increas-
ing the risk for cardiovascular disease (CVD) [1–4]. 
Regarding body fat distribution, abdominal visceral fat 
has been more strongly associated with cardiovascular 
risks than body mass index (BMI), waist circumference, 
and abdominal subcutaneous fat [5, 6]. Therefore, evalu-
ation and management of visceral fat accumulation is 
important to reduce cardio-metabolic burdens. Recently, 
we have reported that increased visceral fat with normal 
BMI is associated with arterial stiffening in patients with 
type 2 diabetes [7]. On the other hand, there is evidence 
that subcutaneous fat has a beneficial role against car-
dio-metabolic risks such as diabetes or dyslipidemia [8, 
9]. These observations suggest the importance of direct 
evaluation of visceral and subcutaneous fat accumula-
tion for the management of atherosclerosis; therefore it 
is possible that increased visceral fat with decreased sub-
cutaneous fat accumulation is positively associated with 
atherosclerosis. Here we investigated the impact of body 
fat distribution, i.e. increased visceral fat with decreased 
subcutaneous fat accumulation, on carotid atherosclero-
sis in Japanese patients with type 2 diabetes.
Methods
Subjects
Patients with type 2 diabetes who regularly visited Tokyo 
Medical and Dental University Hospital participated 
in this study. Patients were eligible, if they were aged 
≥20  years, and 148 consequential patients who under-
went abdominal computed tomography (CT) for the 
assessment of visceral and subcutaneous fat accumula-
tion were enrolled. Patients with severe renal impairment 
[estimated glomerular filtration rate (eGFR) <15  mL/
min/1.73  m2 or undergoing renal replacement therapy], 
pregnant women, and those with infectious or malignant 
diseases were excluded. Type 2 diabetes was diagnosed 
according to the criteria of the Japan Diabetes Society 
(JDS) [10]. This study complies with the principles laid 
by Declaration of Helsinki and has been approved by the 
ethical committee of Tokyo Medical and Dental Univer-
sity (No. 2103).
Clinical and biochemical analysis
Visceral fat area (VFA) and subcutaneous fat area (SFA) 
were measured at the level of umbilicus by abdominal 
CT examination (Aquilion PRIME, Toshiba Medical Sys-
tems, Tochigi, Japan). Atherosclerosis was assessed by 
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S(−)V(−) patients (p = 0.004) and S(+)V(+) (p = 0.036), 
and had a significantly higher VFA-SFA ratio (V/S ratio) 
than S(−)V(−) (p  <  0.001), S(+)V(−) (p  <  0.001), and 
S(+)V(+) patients (p  <  0.001). Systolic blood pressure 
in S(−)V(+) patients were significantly higher than S(−)
V(−) (p  <  0.001) and S(+)V(−) patients (p  <  0.001). 
Interestingly, there were appreciable differences in gen-
der and fat distribution between S(−)V(+) and S(+)
V(−) patients, without a significant difference in BMI. 
In this study, S(−)V(+) patients were male predominant 
(100 % male), and S(+)V(−) patients showed female pre-
dominance (82  % female). Moreover, S(−)V(+) patients 
had significantly higher uric acid (p  <  0.001) and gluta-
myl transpeptidase (γ-GTP) (p < 0.001) levels than S(+)
V(−) patients. The S(−)V(+) patients had reached the 
maximum BMI at younger age (43 ± 12 years) than S(+)
V(−) patients (47  ±  11  years) and S(+)V(+) patients 
(51  ±  13  years). The maximum BMI in S(−)V(+) 
patients was significantly lower than that S(+)V(−) and 
S(+)V(+) patients (data not shown). Medications were 
listed in Table  2. None of S(−)V(+) patients received 
biguanides nor statins, although S(−)V(+) patients 
showed increased visceral fat accumulation. The number 
Fig. 1 The correlation between visceral fat area and subcutaneous 
fat area in patients with type 2 diabetes. SFA subcutaneous fat area 
(cm2), VFA visceral fat area (cm2)
Table 1 Clinical data of patients with type 2 diabetes
Data are expressed as mean ± SD, geometric mean (95 % CI) or percentage
ALT alanine aminotransferase, AST asparatate aminotransferase, CIMT carotid intima media thickness, DBP diastolic blood pressure, eGFR estimated glomerular 
filtration rate, γ-GTP glutamyl transpeptidase, HDL high-density lipoprotein, LDL low-density lipoprotein, PDR proliferative diabetic retinopathy, SBP systolic blood 
pressure
* One-way ANOVA or Chi square test
VFA (cm2) <100 ≥100 p value*
SFA (cm2) <100 (N = 34) ≥100 (N = 39) <100 (N = 11) ≥100 (N = 64)
VFA (cm2) 56 ± 26 74 ± 21 149 ± 34 175 ± 52 <0.001
SFA (cm2) 61 ± 23 157 ± 41 78 ± 16 149 ± 34 <0.001
VFA-to-SFA ratio 1.00 ± 0.43 0.50 ± 0.20 1.98 ± 0.62 0.92 ± 0.33 <0.001
Age (years) 70 ± 10 64 ± 11 72 ± 6 62 ± 12 0.001
Gender (% male) 77 18 100 59 <0.001
BMI (kg/m2) 19.4 ± 2.1 23.2 ± 2.4 22.5 ± 1.8 27.0 ± 3.8 <0.001
SBP (mmHg) 118 ± 15 115 ± 9 136 ± 13 129 ± 11 <0.001
DBP (mmHg) 68 ± 11 66 ± 9 78 ± 15 75 ± 12 <0.001
Current smoker (%) 0 5 18 11 0.111
Duration of diabetes (years) 4.9 (4.2–5.7) 2.6 (2.2–3.2) 3.8 (3.0–4.8) 3.2 (3.1–3.3) 0.120
HbA1c (%) 6.9 ± 1.0 6.7 ± 0.4 6.7 ± 0.4 7.4 ± 1.7 0.024
Triglycerides (mmol/l) 1.36 (1.15–1.61) 1.01 (0.88–1.16) 1.16 (0.79–1.69) 1.67 (1.43–1.96) 0.001
HDL cholesterol (mmol/l) 1.48 ± 0.52 1.50 ± 0.58 1.61 ± 0.42 1.52 ± 0.44 0.900
LDL cholesterol (mmol/l) 2.42 ± 0.72 2.80 ± 1.05 2.80 ± 0.75 2.95 ± 0.82 0.052
Uric acid (μmol/l) 282 ± 85 265 ± 82 395 ± 91 335 ± 58 <0.001
eGFR (ml/min/1.73 m2) 76.8 ± 18.1 73.0 ± 21.5 62.3 ± 22.6 70.6 ± 23.4 0.250
Log ACR (mg/g) 24 (18–31) 23 (15–35) 25 (11–55) 45 (31–68) <0.001
PDR (%) 6 0 0 11 0.128
AST (U/l) 25 (23–27) 21 (19–24) 27 (22–34) 25 (23–28) 0.060
ALT (U/l) 21 (17–25) 16 (14–17) 21 (14–31) 27 (23–31) <0.001
γ-GTP (U/l) 26 (23–31) 23 (21–25) 64 (37–112) 41 (29–59) <0.001
CIMT (mm) 0.86 ± 0.17 0.88 ± 0.07 1.30 0.41 0.81 ± 0.17 <0.001
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of S(+)V(+) patients taking biguanides and statins was 
greater than those of S(−)V(−), S(+)V(−), and S(+)V(+) 
patients.
As expected, S(−)V(+) patients had the highest CIMT 
level among the four groups [vs. S(−)V(−) (p < 0.001), vs. 
S(+)V(−) (p < 0.001), vs. S(+)V(+) (p < 0.001)] (Table 1). 
After adjustment for age and gender, mean (95  % CI) 
of CIMT were 0.80 (0.69–0.91), 0.86 (0.72–1.01), 1.28 
(1.11–1.44) and 0.83 (0.77–0.88) in patients with S(−)
V(−), S(+)V(−), S(−)V(+) and S(+)V(+), respectively 
(p < 0.001). On the other hand, CIMT level in S(+)V(+) 
patients was roughly equivalent to those in S(−)V(−) 
and S(+)V(−) patients. In the univariate analysis, S(−)
V(+) was significantly associated with CIMT (standard-
ized β 0.531, p < 0.001); whereas S(+)V(−) and S(+)V(+) 
were not associated with CIMT (Table  3). In the multi-
variate analysis, S(−)V(+) remained to be significantly 
associated with the risk for CIMT (standardized β 0.423, 
p < 0.001). Adjusted R2 was 0.549 in the model. Notably, 
S(+)V(+) was inversely associated with CIMT in the mul-
tivariate model. Using V/S ratio as the indicator for bal-
ance of visceral and subcutaneous fat accumulation, we 
also examined whether increased visceral fat relative to 
subcutaneous fat is continuously associated with CIMT. 
In this study, V/S ratio showed significantly positive cor-
relations with CIMT in both univariate (Standardized β 
0.506, p < 0.001) and multivariate linear regression analy-
ses (Standardized β 0.383, p < 0.001). We finally underwent 
a sensitivity analysis using the cutoff of 150  cm2 for SFA 
because the average of SFA in this study was approximately 
150 cm2. In the multivariate linear regression analysis, the 
association between SFA < 150 cm2 and VFA ≥ 100 cm2 
and CIMT as compared with SFA  <  150  cm2 and 
VFA < 100 cm2 reached a marginal statistical significance 
(Standardized β 0.190, p = 0.051); whereas, patients with 
SFA ≥ 150 cm2 and VFA ≥ 100 cm2 were not significantly 
increased risk for CIMT.
Discussion
Here, we demonstrate that S(−)V(+) patients are at an 
significantly increased risk for carotid atherosclerosis 
among Japanese patients with type 2 diabetes. Moreover, 
in multivariate analyses, there was a direct relationship 
between the presence of S(−)V(+) and risk for athero-
sclerosis and an inverse relationship between the pres-
ence of S(+)V(+) and risk for CIMT.
Table 2 Medications of patients with type 2 diabetes
Data are expressed as percentage
ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker, DPP4 dipeptidyl peptidase-4, GI glycosidase inhibitor, 
GLP-1 glucagon-like peptide-1, OHA oral hypoglycemic agent, TZD thiazolidinedione, UA uric acid
* Chi square test
VFA (cm2) <100 ≥100 p value*
SFA (cm2) <100 (N = 34) ≥100 (N = 39) <100 (N = 11) ≥100 (N = 34)
OHA (%) 41.2 33.3 54.5 54.7 0.164
Sulfonylureas (%) 25.0 0.0 12.5 22.4 0.055
Biguanides (%) 16.7 15.4 0.0 40.8 0.012
Alpha-GIs (%) 25.0 0.0 12.5 10.2 0.048
TZDs (%) 8.3 0.0 7.7 6.1 0.301
DPP4 inhibitors (%) 25.0 42.3 62.5 34.7 0.245
Glinides (%) 8.3 0.0 0.0 0.0 0.070
GLP-1 agonists (%) 0.0 0.0 0.0 2.0 0.754
Insulin (%) 41.2 38.5 18.2 35.9 0.575
ACEIs (%) 0.0 5.4 0.0 3.2 0.516
ARBs (%) 17.6 24.3 45.5 44.4 0.025
CCBs (%) 11.8 5.4 36.4 30.2 0.007
Beta blockers (%) 5.9 18.9 18.2 14.3 0.424
Alpha blockers (%) 0.0 5.4 0.0 1.6 0.383
Diuretics (%) 5.9 24.3 9.1 11.1 0.110
Statins (%) 11.8 16.2 0.0 34.9 0.007
Fibrates (%) 0.0 0.0 0.0 3.2 0.451
UA-lowering agents 0.0 10.8 9.1 6.3 0.289
Anti-platelets (%) 11.8 0.0 9.1 12.7 0.168
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The association between body fat accumulation 
and atherosclerosis
Visceral adipose tissue has been recently reported to 
be associated with coronary plaque characteristics in 
patients without diabetes [13] and visceral adipose tissue 
is a stronger risk factor of carotid atherosclerosis in Chi-
nese adults [14]. Therefore, our data support the notion 
that visceral fat accumulation is positively associated 
with atherosclerosis. By contrast, Ravussin and Smith 
[15, 16] proposed the possibility that the ability to retain 
fat in subcutaneous depot is beneficial against cardio-
metabolic risks. In addition, a more recent study clearly 
revealed that subcutaneous adipose thickness assessed by 
ultrasonography is inversely associated with carotid ath-
erosclerosis in patients with type 2 diabetes [17]. These 
observations taken together, suggest that body fat distri-
bution should be evaluated with information on visceral 
and subcutaneous fat accumulation for the assessment of 
the risks for atherosclerosis.
Possible factors associated with fat distribution 
and atherosclerosis
In this study, S(−)V(+) patients were elderly men with 
severe cardio-metabolic profiles, including elevated 
blood pressure and uric acid, and high V/S ratio. These 
observations may partly explain the progression of ath-
erosclerosis in S(−)V(+) patients. In addition, S(−)V(+) 
patients had reached maximum BMI at younger age than 
S(+)V(−) and S(+)V(+) patients. The maximum BMI 
in S(−)V(+) patients was low relative to S(+)V(−) and 
S(+)V(+) patients. It is interesting to speculate that S(−)
V(+) patients have lower capacity to store excess energy 
in subcutaneous fat depot than S(+)V(−) and S(+)V(+) 
patients. Then, what could affect body fat distribution? 
A recent large scale cross-sectional study demonstrated 
that abdominal adiposity is positively associated with a 
deteriorated cardio-metabolic risk profile in multi-eth-
nicities and that East Asians have the highest visceral 
relative to subcutaneous fat accumulation among whites, 
African Caribbean blacks, Hispanics, East Asians, and 
Southeast Asians [18]. The Japanese men are likely to 
have a greater percent body fat than Australian men at 
any given BMI values [19]. Gender is also an important 
determinant of body fat distribution. Indeed, a genome-
wide association study meta-analysis showed sexual 
dimorphism in the genetic regulation of fat distribution 
traits [20]. In this study, there was a clear gender differ-
ence in body fat distribution, with male predominance 
in S(−)V(+) and female predominance in S(+)V(−). 
It has been observed that high fat stores in ectopic fat 
compartments including skeletal muscle are present in 
male patients newly diagnosed with type 2 diabetes and 
altered lipid partitioning within muscle is independently 
associated with carotid atherosclerosis [21]. Després has 
recently proposed the lipid overflow-ectopic fat model 
[22]. If the extra energy is channeled into insulin-sen-
sitive subcutaneous adipose tissue, the subjects will be 
protective against the development of the metabolic syn-
drome; whereas, in cases where the adipose tissue has a 
limited ability to store the excess energy into subcutane-
ous adipose tissue, triglycerides surplus will be deposited 
at undesirable sites such as skeletal muscle and visceral 
adipose tissue, leading the insulin resistance, atherogenic 
dyslipidemia, and atherosclerosis. Therefore, it is possi-
ble that low capacity of subcutaneous fat accumulation 
in patients with S(−)V(+) could allow ectopic fat accu-
mulation within muscle as well as visceral fat accumula-
tion, consequently leading to increased risk for carotid 
atherosclerosis. It remains to be determined whether the 
association observed between S(−)V(+) and atheroscle-
rosis in Japanese subjects with type 2 diabetes will also 
be observed in other populations.
Limitations
There are a couple of limitations in this study. First, it is 
impossible to infer causality because of its cross-sectional 
design. Second, we evaluated visceral fat and subcutane-
ous fat accumulation using VFA and SFA at the level of 
Table 3 Linear regression analysis for risk factors of intima 
media thickness in patients with type 2 diabetes
Covariates; age, gender, history of cardiovascular disease, systolic blood 
pressure, duration of diabetes, current smoking, HbA1c, low-density lipoprotein 
cholesterol, high-density lipoprotein cholesterol, logarithmically transformed 
triglycerides, C-reactive protein, eGFR, albuminuria, the use of insulin, oral 
hypoglycemic agents, renin-angiotensin system blockers, calcium channel 
blockers and statins
ACR albumin-to-creatinine ratio, CCB calcium channel blocker, SFA subcutaneous 
fat area, VFA visceral fat area
Standardized β p values
Univariates
 SFA ≥ 100 cm2 and VFA < 100 cm2 [S(+)
V(−)]
0.032 0.813
 SFA < 100 cm2 and VFA ≥ 100 cm2 [S(−)
V(+)]
0.531 <0.001




 SFA ≥ 100 cm2 and VFA < 100 cm2 [S(+)
V(−)]
−0.100 0.386
 SFA < 100 cm2 and VFA ≥ 100 cm2 [S(−)
V(+)]
0.423 <0.001




Urinary ACR 0.299 0.001
CCBs −0.171 0.023
Duration of diabetes 0.156 0.049
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umbilicus; therefore, fat accumulation in other fat depots 
such as thighs and legs were not evaluated. Third, popu-
lation in this study was ethnically and socially homoge-
neous, because this study was hospital-based; therefore, 
generalization of our findings might be limited. Fourth, 
we were unable to obtain information on diet and exer-
cise in this study. These lifestyle could affect the distribu-
tion of body fat and BMI levels and could be one of the 
variables that is accounting for this high risk of CIMT 
in patients with S(−)V(+). Finally, it is important to 
undergo the sub-analyses to investigate the association of 
VFA and SFA accumulation with CIMT in different age 
groups, gender, and metabolic status; however, we could 
not undergo the analyses due to the relatively small sam-
ple size.
Conclusions
It is of primary importance to identify diabetic patients 
who have advanced atherosclerosis because they are 
at extremely increased risk for CVD [23, 24]. Our data 
suggest that imbalance of visceral and subcutaneous fat 
distribution, i.e. increased visceral fat with decreased 
subcutaneous fat accumulation, is an important deter-
minant of atherosclerosis, whereas increased subcu-
taneous fat accumulation could buffer the deleterious 
effect of visceral fat accumulation in patients with type 
2 diabetes.
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